ProShares UltraShort Nasdaq Biotechnology (BIS) Holdings $15.50 -0.04 (-0.26%) (As of 11/4/2024 ET) Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipShort InterestTrends Top 8 BIS HoldingsRankCompanyCurrent PriceWeightShares Held1NET OTHER ASSETS (LIABILITIES)N/A0.00%1,938,4172TREASURY BILLN/A0.00%1,500,0003NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A-8.08%-594NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLCN/A-15.75%-1155NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A-27.40%-2006NASDAQ BIO INDEX SWAP BNP PARIBASN/A-31.37%-2297NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A-52.61%-3848NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A-64.52%-471 Geographic ExposureUnited States42.6%Currency ExposureUSD68.7% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Holdings First Trust Nasdaq Pharmaceuticals ETF Holdings Horizon Kinetics Medical ETF Holdings Invesco Nasdaq Biotechnology ETF Holdings ProShares Ultra Nasdaq Biotechnology Holdings Invesco Dorsey Wright Healthcare Momentum ETF Holdings Invesco S&P SmallCap Health Care ETF Holdings VanEck Biotech ETF Holdings VanEck Pharmaceutical ETF Holdings iShares Biotechnology ETF Holdings This page (NASDAQ:BIS) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
